Image of Jamie Bayona

Jaime Bayona, MD, MPH

Lecturer on Global Health and Social Medicine
603-277-0412

Jaime Bayona, MD, MPH is the Founding Director of Socios En Salud Sucursal Peru (SES), a Lima-based organization that has had significant impact on policies for prevention and treatment of drug-resistant tuberculosis (TB) and HIV and provided training and technical assistance around the world.

A leader in international health and social medicine, Dr Bayona is an authority on programmatic approaches to the control of multidrug-resistant TB and a long-time advocate for community-based primary care. He is the author of numerous publications related to TB control and treatment methods and is currently a co-investigator in a multi-institutional grant funded by the US National Institutes of Health to study the epidemiology of multidrug-resistant TB in Lima.

Dr Bayona received his MD in 1986 from The School of Medicine, National University of Trujillo in Peru and his MPH in 1992 from the Joint Center for Public Health Studies, College of Medicine, University of Wales, UK

Dr. Bayona's research focuses on the epidemiology of tuberculosis, multidrug-resistant tuberculosis, extremely drug-resistant tuberculosis, HIV/AIDS, community-based approaches to dealing with public health problems, social responsibility, and public health approaches in global health. He is also working on the performance evaluation of primary health system is several countries.

Multidrug-resistant tuberculosis and the need for biosocial perspectives.
Authors: Authors: Farmer P, Bayona J, Becerra M.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis.
Authors: Authors: Furin JJ, Mitnick CD, Shin SS, Bayona J, Becerra MC, Singler JM, Alcantara F, Castañieda C, Sanchez E, Acha J, Farmer PE, Kim JY.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Redefining MDR-TB transmission 'hot spots'.
Authors: Authors: Becerra MC, Bayona J, Freeman J, Farmer PE, Kim JY.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains.
Authors: Authors: Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE.
Eur J Clin Microbiol Infect Dis
View full abstract on Pubmed
Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Authors: Authors: Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Management of MDR-TB in resource-poor countries.
Authors: Authors: Farmer P, Furin J, Bayona J, Becerra M, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S.
Int J Tuberc Lung Dis
View full abstract on Pubmed
The dilemma of MDR-TB in the global era.
Authors: Authors: Farmer P, Bayona J, Becerra M, Furin J, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S.
Int J Tuberc Lung Dis
View full abstract on Pubmed